It did not appear that these changes in expression were directly associated with TGFβ signaling and furthermore, an inhibitor to the TGFβR1 (activin-like kinase 5, ALK-5) could not completely attenuate bleomycin-induced fibrosis in mice. The gene discussed is TGFBR1; the disease is fibrosis.